Nathaniel Mabe, Ph.D., Pharm.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammary Neoplasms, Animal | 2 | 2020 | 140 | 0.980 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2018 | 1140 | 0.620 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 692 | 0.610 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2020 | 8610 | 0.590 |
Why?
|
Gene Silencing | 2 | 2020 | 1668 | 0.560 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2020 | 690 | 0.550 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2020 | 115 | 0.400 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2020 | 8895 | 0.380 |
Why?
|
Tumor Suppressor Proteins | 1 | 2018 | 2902 | 0.340 |
Why?
|
RGS Proteins | 2 | 2016 | 83 | 0.270 |
Why?
|
Mice, Nude | 3 | 2020 | 4040 | 0.260 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2018 | 5265 | 0.240 |
Why?
|
Inflammation | 2 | 2020 | 9617 | 0.220 |
Why?
|
Cystine | 1 | 2020 | 90 | 0.200 |
Why?
|
Up-Regulation | 2 | 2020 | 4441 | 0.190 |
Why?
|
Histone Deacetylase 2 | 1 | 2018 | 73 | 0.180 |
Why?
|
Histone Deacetylase 1 | 1 | 2018 | 126 | 0.180 |
Why?
|
Breast Neoplasms | 3 | 2020 | 19153 | 0.170 |
Why?
|
G-Protein-Coupled Receptor Kinase 2 | 1 | 2016 | 9 | 0.170 |
Why?
|
Mitochondria, Heart | 1 | 2016 | 246 | 0.150 |
Why?
|
Cell Death | 1 | 2020 | 1769 | 0.140 |
Why?
|
Caspase 3 | 1 | 2016 | 807 | 0.130 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2020 | 2912 | 0.120 |
Why?
|
Cell Survival | 2 | 2020 | 6288 | 0.120 |
Why?
|
GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2011 | 32 | 0.110 |
Why?
|
Forkhead Transcription Factors | 1 | 2018 | 1551 | 0.100 |
Why?
|
Epigenesis, Genetic | 2 | 2020 | 3337 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2020 | 4477 | 0.090 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2011 | 487 | 0.080 |
Why?
|
Cell Line, Tumor | 3 | 2020 | 17251 | 0.080 |
Why?
|
Myocardial Ischemia | 1 | 2016 | 2092 | 0.080 |
Why?
|
Transcription, Genetic | 1 | 2020 | 8130 | 0.070 |
Why?
|
Animals | 7 | 2020 | 170849 | 0.060 |
Why?
|
Myocardial Infarction | 2 | 2016 | 11266 | 0.060 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2019 | 3736 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2018 | 6009 | 0.060 |
Why?
|
Myocardium | 2 | 2016 | 5024 | 0.060 |
Why?
|
Tumor Stem Cell Assay | 1 | 2020 | 127 | 0.050 |
Why?
|
Doxycycline | 1 | 2020 | 308 | 0.050 |
Why?
|
Cats | 1 | 2019 | 1050 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2020 | 603 | 0.040 |
Why?
|
Mice | 3 | 2018 | 80803 | 0.040 |
Why?
|
Female | 6 | 2020 | 375459 | 0.040 |
Why?
|
Protective Agents | 1 | 2016 | 168 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13898 | 0.040 |
Why?
|
Mitosis | 1 | 2020 | 1276 | 0.030 |
Why?
|
Risk Factors | 1 | 2020 | 69278 | 0.030 |
Why?
|
Signal Transduction | 4 | 2020 | 24351 | 0.030 |
Why?
|
Fibrosis | 1 | 2019 | 1798 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3881 | 0.030 |
Why?
|
KATP Channels | 1 | 2011 | 45 | 0.030 |
Why?
|
Drug Design | 1 | 2016 | 1150 | 0.030 |
Why?
|
Receptor, erbB-2 | 1 | 2020 | 2212 | 0.030 |
Why?
|
Potassium Channel Blockers | 1 | 2011 | 172 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2011 | 387 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2048 | 0.030 |
Why?
|
Piperazines | 1 | 2020 | 2576 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 3006 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2568 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2018 | 2833 | 0.020 |
Why?
|
Potassium Channels | 1 | 2011 | 573 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3557 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2011 | 563 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2011 | 2009 | 0.020 |
Why?
|
Perfusion | 1 | 2011 | 1270 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2019 | 3196 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18495 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 6150 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2011 | 1680 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2019 | 4151 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10990 | 0.020 |
Why?
|
Rats | 1 | 2019 | 25307 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2011 | 6685 | 0.010 |
Why?
|
Humans | 3 | 2020 | 686663 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 15597 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 11616 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2020 | 12009 | 0.010 |
Why?
|
Genotype | 1 | 2011 | 13073 | 0.010 |
Why?
|
Phenotype | 1 | 2011 | 16091 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 23439 | 0.010 |
Why?
|
Male | 2 | 2019 | 352465 | 0.010 |
Why?
|
Mutation | 1 | 2011 | 28848 | 0.000 |
Why?
|